Hanmi Pharm. Co., Ltd.
128940.KS
₩520,000
Updated: 24/09/2026, 05:13:36
Market Cap
₩6.59T
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
KR
Stock valuation chart
One-year closing share-price history for 128940.KS
Company Profile
A globally active pharmaceutical company, Hanmi Pharm. Co., Ltd. was established in Seoul, South Korea, in 1973. The firm concentrates its efforts on researching and developing medical therapies for a range of health issues, including diabetes, obesity, cancer, autoimmune disorders, and various rare diseases.
KRW
KSC
CEO: Jae-Hyun Park
Employees: 2,270
Asset Summaries
Latest generated summaries for 128940.KS
No summaries found.
Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for 128940.KS.
- Share price
- ₩520,000
- Market cap
- ₩6.59T
- Exchange
- KSC
- Currency
- KRW
- CEO
- Jae-Hyun Park
- Employees
- 2,270
- IPO date
- 30/07/2010
- Beta
- 0.487
- Last dividend
- ₩0
- Day range
- ₩506,000 – ₩534,000
- 52-week range
- ₩302,000 – ₩647,000
- 1-day performance
- 3.59%
- 1-year performance
- 72.19%
- Current drawdown (1Y)
- -19.63%
- CIK
- N/A
- CUSIP
- N/A
- ISIN
- KR7128940004
- Created
- 07/09/2026, 05:16:02
- Last update
- 24/09/2026, 05:13:36
Track Hanmi Pharm. Co., Ltd. with an AI analyst
See which prediction-market events move 128940.KS, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
Latest Database News
News linked to 128940.KS from your Railway `news_articles` table.
No news found for this symbol.